Fierce Biotech8h
Pliant, Acelyrin resort to ‘poison pills’ as threat of Concentra buyout looms
With Concentra Biosciences expanding its stock influence in Pliant Therapeutics and Acelyrin, the two biotechs have shored up ...
BioSpace9h
Pliant Pops Poison Pill as Concentra Threat Looms
Pliant follows in the footsteps of Acelyrin, which also enacted a stockholder rights program on Thursday to protect ...
BioPharma Dive6h
Makary advances to full senate vote; Acelyrin, Pliant adopt ‘poison pills’
President Trump’s nominee to run the FDA secured the Senate HELP Committee’s backing. Elsewhere, Sutro cut jobs and a cell ...
Endpoints News1d
Ace­lyrin, Pli­ant turn to ‘poi­son pill’ as Kevin Tang’s Con­cen­tra pur­sues both com­pa­nies
Acelyrin and Pliant Therapeutics, both of which are viewed as takeover targets for Kevin Tang’s Concentra Biosciences, each adopted a “poison pill” on Thursday morning.
BioSpace1d
Acelyrin Adopts Poison Pill to Ward Off Tang Capital Buy
The move by Acelyrin’s board comes as the venture capital firm has taken larger and larger stakes in the company in an ...
RBR15d
Cumulus Drops ‘Poison Pill’ Plan as Takeover Concerns Fade
One year ago, Cumulus Media initiated a “poison pill” defense to stave off the looming threat of a hostile takeover from billionaire Manoj Bhargava, who had been in acquisition mode with his ...